14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 63 days ( -5.87 % )
Last Price $0.397 0 %
High/ Low $0.397 - $0.397 0%
Chg 7 Days N/A $0.397 $0.397
Chg 30 Days N/A $0.397 $0.397
Chg 12 mos -80.05 % $1.99 $0.397
Trend - 3 mos 0.270 % Width: 2.00 %
Trend - 12 mos -54.63 % Width: 332.11 %
Pred. range - 3 mos $0.391 - $0.399 -1.53 % - 0.443 %
Pred. range - 12 mos N/A - $0.398 -100.00 % - 0.342 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Nov 28, 2022 - 63 days
Long MA avg 12 mos Buy Nov 28, 2022 - 63 days
Short/Long MA avg 12 mos Buy Nov 28, 2022 - 63 days
Pivot Short Sell Feb 27, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT